Hjem
Ingfrid Salvesen Haldorsens bilde

Ingfrid Salvesen Haldorsen

Professor, Radiologist
  • E-postIngfrid.Haldorsen@uib.no
  • Telefon+47 954 04 470
  • Besøksadresse
    Dep. of Radiology
    Haukeland University Hospital
    5021 Bergen
    Rom 
    MMIV, 5. etg. Haraldsplass
  • Postadresse
    Postboks 7804
    5020 Bergen

Ingfrid Haldorsen er lege og spesialist i radiologi med lang klinisk erfaring innen abdominal- og gynekologisk radiologi. Hun disputerte i 2009 og har siden 2013 vært ansatt i bistilling som professor i radiologi ved UiB. Siden 2020 har Ingfrid Haldorsen ledet Mohn Medical Imaging and Visualization Centre. Forskningsgruppen hennes Bergen Cancer Imaging Research Group jobber særlig med gynekologisk kreftavbildning og samarbeider tett med Bergen gynekologiske kreftforskningsgruppe ved Kvinneklinikken/UiB.

Vitenskapelig artikkel
  • Vis forfatter(e) 2021. The role of sarcopenic obesity in high-grade endometrial cancer. International Journal of Gynecology & Obstetrics.
  • Vis forfatter(e) 2021. Obesity and visceral fat: Survival impact in high-grade endometrial cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 425-432.
  • Vis forfatter(e) 2021. Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography. European Journal of Radiology. 1-9.
  • Vis forfatter(e) 2021. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. American Journal of Obstetrics and Gynecology. 1-20.
  • Vis forfatter(e) 2021. Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening. Radiology. 66-76.
  • Vis forfatter(e) 2021. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. Gynecologic Oncology. 787-794.
  • Vis forfatter(e) 2021. Feasibility and utility of MRI and dynamic <sup>18</sup>F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer. Journal of Translational Medicine. 1-13.
  • Vis forfatter(e) 2021. Diagnostic Accuracy of Computed Tomography Scores in Chronic Pancreatitis. Pancreas. 549-555.
  • Vis forfatter(e) 2021. Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 25-31.
  • Vis forfatter(e) 2021. Automated segmentation of endometrial cancer on MR images using deep learning. Scientific Reports.
  • Vis forfatter(e) 2021. An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. Journal of Clinical Medicine. 1-11.
  • Vis forfatter(e) 2021. A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. British Journal of Cancer. 1690-1698.
  • Vis forfatter(e) 2020. Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. Journal of Magnetic Resonance Imaging. 1-10.
  • Vis forfatter(e) 2020. Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. Clinical Radiology. 1-8.
  • Vis forfatter(e) 2020. Systematic approach for assessment of imaging features in chronic pancreatitis: a feasibility and validation study from the Scandinavian Baltic Pancreatic Club (SBPC) database. Abdominal Radiology. 1468-1480.
  • Vis forfatter(e) 2020. Secretin-stimulated magnetic resonance imaging reveals variable diagnostic accuracy according to etiology in pancreatic disease. Pancreas. 361-367.
  • Vis forfatter(e) 2020. RadEx: Integrated visual exploration of multiparametric studies for radiomic tumor profiling. Computer Graphics Forum. 611-622.
  • Vis forfatter(e) 2020. Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. PLoS Medicine.
  • Vis forfatter(e) 2020. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. European Radiology. 2443-2453.
  • Vis forfatter(e) 2020. ParaGlyder: Probe-driven Interactive Visual Analysis for Multiparametric Medical Imaging Data. Lecture Notes in Computer Science (LNCS). 351-363.
  • Vis forfatter(e) 2020. Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. Cancers. 1-18.
  • Vis forfatter(e) 2020. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. Gynecologic Oncology. 1-9.
  • Vis forfatter(e) 2020. Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients. Acta Radiologica. 1570-1579.
  • Vis forfatter(e) 2020. High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. Gynecologic Oncology. 260-267.
  • Vis forfatter(e) 2020. Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. British Journal of Cancer. 1014-1022.
  • Vis forfatter(e) 2020. Comparing screening outcomes for digital breast tomosynthesis and digital mammography by automated breast density in a randomized controlled trial: Results from the to-be trial. Radiology. 522-531.
  • Vis forfatter(e) 2019. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. The Lancet Oncology. 795-805.
  • Vis forfatter(e) 2019. Poor outcome in hypoxic endometrial carcinoma is related to vascular density. British Journal of Cancer. 1037-1044.
  • Vis forfatter(e) 2019. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLOS ONE. 1-13.
  • Vis forfatter(e) 2019. Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study. BMC Cancer. 1-8.
  • Vis forfatter(e) 2019. Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. Gynecologic Oncology. 400-406.
  • Vis forfatter(e) 2019. Blood metabolites associate with prognosis in endometrial cancer. Metabolites. 1-15.
  • Vis forfatter(e) 2018. Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI. PLOS ONE. 1-16.
  • Vis forfatter(e) 2018. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. Journal of Magnetic Resonance Imaging. 1637-1647.
  • Vis forfatter(e) 2018. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiologica. 1010-1017.
  • Vis forfatter(e) 2018. Guidelines for the diagnostic cross sectional imaging and severity scoring of chronic pancreatitis. Pancreatology (Print). 764-773.
  • Vis forfatter(e) 2018. Good agreement between transabdominal and endoscopic ultrasound of the pancreas in chronic pancreatitis. Ultraschall in der Medizin. 1-9.
  • Vis forfatter(e) 2018. Development of an image-guided orthotopic xenograft mouse model of endometrial cancer with controllable estrogen exposure. International Journal of Molecular Sciences. 1-16.
  • Vis forfatter(e) 2018. Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries—Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology. Acta Obstetricia et Gynecologica Scandinavica. 1178-1184.
  • Vis forfatter(e) 2018. Blood steroids are associated with prognosis and fat distribution in endometrial cancer. Gynecologic Oncology. 46-52.
  • Vis forfatter(e) 2018. Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. BJOG: An International Journal of Obstetrics and Gynaecology. 1695-1703.
  • Vis forfatter(e) 2018. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial. European Radiology.
  • Vis forfatter(e) 2017. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. OncoTarget. 109018-109026.
  • Vis forfatter(e) 2017. The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort. Scandinavian Journal of Gastroenterology. 909-915.
  • Vis forfatter(e) 2017. Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging. European Radiology. 1495-1503.
  • Vis forfatter(e) 2017. Secretin-stimulated MRI characterization of pancreatic morphology and function in patients with chronic pancreatitis. Pancreatology (Print). 228-236.
  • Vis forfatter(e) 2017. Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. OncoTarget. 68530-68541.
  • Vis forfatter(e) 2017. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. Acta Radiologica. 497-505.
  • Vis forfatter(e) 2017. High visceral fat percentage is associated with poor outcome in endometrial cancer. OncoTarget. 105184-105195.
  • Vis forfatter(e) 2017. HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 378-387.
  • Vis forfatter(e) 2017. Diagnostic accuracy of transabdominal ultrasound in chronic pancreatitis. Ultrasound in Medicine and Biology. 735-743.
  • Vis forfatter(e) 2017. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. American Journal of Obstetrics and Gynecology. 432.e1-432.e17.
  • Vis forfatter(e) 2016. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. OncoTarget. 69844-69856.
  • Vis forfatter(e) 2016. Texture analysis of 2D spatial distribution of blood pharmacokinetic model parameters for endometrial carcinoma classification. Signal Processing - Algorithms, Architectures, Arrangements, and Applications Conference Proceedings, SPA. 91-96.
  • Vis forfatter(e) 2016. Single-session alcohol sclerotherapy of symptomatic liver cysts using 10-20 min of ethanol exposure: no recurrence at 2-16 years of follow-up. Abdominal Radiology. 1776-1781.
  • Vis forfatter(e) 2016. Secretin-stimulated MRI assessment of exocrine pancreatic function in patients with cystic fibrosis and healthy controls. Abdominal Radiology. 1-10.
  • Vis forfatter(e) 2015. Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. Clinical Radiology. 487-494.
  • Vis forfatter(e) 2015. Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. International Journal of Gynecological Cancer. 459-466.
  • Vis forfatter(e) 2015. Multimodal imaging of orthotopic mouse model of endometrial carcinoma. PLOS ONE. 11 sider.
  • Vis forfatter(e) 2015. Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. Journal of Nuclear Medicine. 1191-1198.
  • Vis forfatter(e) 2015. Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
  • Vis forfatter(e) 2015. Endorectal ultrasonography, strain elastography and MRI differentiation of rectal adenomas and adenocarcinomas. Colorectal Disease. 124-131.
  • Vis forfatter(e) 2014. Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. British Journal of Cancer. 107-114.
  • Vis forfatter(e) 2014. Carboxyl-ester lipase maturity-onset diabetes of the young is associated with development of pancreatic cysts and upregulated MAPK signaling in secretin-stimulated duodenal fluid. Diabetes. 259-269.
  • Vis forfatter(e) 2014. Assessment of Exocrine Pancreatic Function by Secretin-Stimulated Magnetic Resonance Cholangiopancreaticography and Diffusion-Weighted Imaging in Healthy Controls. Journal of Magnetic Resonance Imaging. 448-454.
  • Vis forfatter(e) 2013. Severe pancreatic dysfunction but compensated nutritional status in monogenic pancreatic disease caused by carboxyl-ester lipase mutations. Pancreas. 1078-1084.
  • Vis forfatter(e) 2013. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. American Journal of Human Genetics. 150-157.
  • Vis forfatter(e) 2013. Exocrine pancreatic function in hepatocyte nuclear factor 1 beta-maturity-onset diabetes of the young (HNF1B-MODY) is only moderately reduced: compensatory hypersecretion from a hypoplastic pancreas. Diabetic Medicine. 946-955.
  • Vis forfatter(e) 2013. Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. European Radiology. 2916-2925.
  • Vis forfatter(e) 2012. Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. European Radiology. 1601-1611.
  • Vis forfatter(e) 2012. Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. Gynecologic Oncology. 413-418.
  • Vis forfatter(e) 2012. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatric Diabetes. e1-e5.
  • Vis forfatter(e) 2011. The role of pancreatic imaging in monogenic diabetes. Nature Reviews Endocrinology.
  • Vis forfatter(e) 2011. Double reading of radiological examinations in Norway. Acta Radiologica. 516-521.
  • Vis forfatter(e) 2011. Central nervous system lymphoma: Characteristic findings on traditional and advanced imaging. American Journal of Neuroradiology. 984-992.
  • Vis forfatter(e) 2009. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. American Journal of Neuroradiology. 744-751.
  • Vis forfatter(e) 2008. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. Journal of Clinical Endocrinology and Metabolism. 3505-3509.
  • Vis forfatter(e) 2008. Lack of pancreatic body and tail in HNF1B mutation carriers. Diabetic Medicine. 782-787.
  • Vis forfatter(e) 2008. AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer. 8 sider.
  • Vis forfatter(e) 2007. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-Ester lipase. Diabetes. 444-449.
  • Vis forfatter(e) 2007. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 - Time trends in a 15-year national survey. Cancer. 1803-1814.
  • Vis forfatter(e) 2006. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics. 54-62.
Vitenskapelig foredrag
  • Vis forfatter(e) 2019. Early Performance Measures Among Women Screened with DBT after a Prior DBT or a Prior DM, in a National Screening Program.
  • Vis forfatter(e) 2015. Preoperative tumor texture at MRI predicts deep myometrial invasion and non-endometrioid subtype in endometrial carcinomas.
  • Vis forfatter(e) 2014. Functional imaging for individualized cancer treatment.
  • Vis forfatter(e) 2011. Modest agreement between radiologists on pelvic MR imaging findings in endometrial carcinomas.
Vitenskapelig antologi/Konferanseserie
  • Vis forfatter(e) 2015. Innovation in Imaging & Vizualization. The MedViz Conference 2015. Allkopi Forlag.
Populærvitenskapelig artikkel
  • Vis forfatter(e) 2011. Bildediagnostikk av pankreas ved monogen diabetes. Diabetesforum. 20-22.
Doktorgradsavhandling
  • Vis forfatter(e) 2017. Molecular alterations and diagnostic imaging in premalignant and malignant endometrial lesions for improved diagnosis and treatment.
  • Vis forfatter(e) 2016. Functional imaging to promote individualized and targeted therapy in endometrial cancer.
  • Vis forfatter(e) 2009. Primary central nervous system lymphoma in Norway 1989-2003.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) 2015. Rosemont score from transabdominal ultrasound in chronic pancreatitis. 3 sider.
  • Vis forfatter(e) 2012. Epidemiology of Primary Central Nervous System Lymphoma. 9 sider.
Sammendrag/abstract
  • Vis forfatter(e) 2013. Value of preoperative 2-deoxy-2-[18F]fluoroglucose positron emission tomography/computer tomography (FDG-PET/CT) in endometrial carcinomas. Acta Radiologica. 13-13.
  • Vis forfatter(e) 2013. Assessment of exocrine pancreatic funtion by secretin-stimulated MRCP and DWI in healthy controls and in patients with monogenic diabetes. Acta Radiologica. 13-13.
Poster
  • Vis forfatter(e) 2018. Research Agenda of the Mohn Medical Imaging and Visualization Centre in Bergen, Norway.
  • Vis forfatter(e) 2015. Secretin stimulated MRCP in the evaluation of exocrine pancreatic function in cystic fibrosis.
  • Vis forfatter(e) 2015. Rosemont score from transabdominal ultrasound in chronic pancreatitis.
  • Vis forfatter(e) 2014. Metabolic tumor volume on FDG-PET/CT predicts deep myometrial invasion, lymph node metastases and survival in patients with endometrial carcinoma .
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2019. What is the role of imaging at primary diagnostic work-up in uterine cervical cancer? Current Oncology Reports. 1-15.
  • Vis forfatter(e) 2019. Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. Cancers. 1-16.
  • Vis forfatter(e) 2019. Diagnostic accuracy of clinical biomarkers for preoperative prediction of lymph node metastasis in endometrial carcinoma: A systematic review and meta-analysis. The Oncologist. e880-e890.
  • Vis forfatter(e) 2016. What is the best breoperative imaging for endometrial cancer? Current Oncology Reports. 1-11.
  • Vis forfatter(e) 2016. Secretin-Stimulated Magnetic Resonance Imaging Assessment of the Benign Pancreatic Disorders: Systematic Review and Proposal for a Standardized Protocol. Pancreas. 1092-1103.
  • Vis forfatter(e) 2016. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature. Journal of Nuclear Medicine. 879-885.
  • Vis forfatter(e) 2012. The role of pancreatic imaging in monogenic diabetes mellitus. Nature Reviews Endocrinology. 148-159.
  • Vis forfatter(e) 2012. Staging of endometrial carcinomas with MRI using traditional and novel MRI techniques. Clinical Radiology. 2-12.
  • Vis forfatter(e) 2012. Markers for individualised therapy in endometrial carcinoma. The Lancet Oncology. E353-E361.
Fagartikkel
  • Vis forfatter(e) 2011. Erfaringer fra en teleradiologisk klinikk i India. Noraforum : tidsskrift for radiologi. 24-26.

Se fullstendig oversikt over publikasjoner i CRIStin.

  • M. K. Halle, M. Sødal, D. Forsse, H. Engerud, K. Woie, N. G. Lura, K. S. Wagner-Larsen, J. Trovik, B. I. Bertelsen, I. S. Haldorsen, and others, “A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease,” British journal of cancer, vol. 124, iss. 10, pp. 1690-1698, 2021. doi:10.1038/s41416-021-01305-0[BibTeX] [Download PDF]
  • S. W. Vrede, W. J. van Weelden, N. C. M. Visser, J. Bulten, L. J. M. van der Putten, K. van de Vijver, M. Santacana, E. Colas, A. Gil-Moreno, C. P. Moiola, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, J. Huvila, M. Koskas, V. Weinberger, M. Bednarikova, J. Hausnerova, A. A. van der Wurff, X. Matias-Guiu, F. Amant, M. P. L. M. Snijders, H. V. N. Küsters-Vandevelde, C. Reijnen, and J. M. A. Pijnenborg, “Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer,” Gynecologic Oncology, vol. 161, iss. 3, pp. 787-794, 2021. doi:https://doi.org/10.1016/j.ygyno.2021.03.031[BibTeX] [Download PDF]
  • I. K. Nordaas, G. Dimcevski, O. H. Gilja, R. F. Havre, I. S. Haldorsen, and T. Engjom, “Diagnostic Accuracy of Computed Tomography Scores in Chronic Pancreatitis,” Pancreas, vol. 50, iss. 4, pp. 549-555, 2021. doi:10.1097/MPA.0000000000001803[BibTeX] [Download PDF]
  • H. Aase, A. Danielsen, S. Hoff, ÅS. Holen, I. Haldorsen, T. Hovda, B. Hanestad, C. Sandvik, and S. Hofvind, “Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography,” European Journal of Radiology, p. 109753, 2021. doi:https://doi.org/10.1016/j.ejrad.2021.109753[BibTeX] [Download PDF]
  • T. Engjom, I. K. Nordaas, E. Tjora, G. Dimcevski, I. S. Haldorsen, S. S. Olesen, A. M. Drewes, K. Zviniene, G. Barauskas, H. R. Søe. Jespersen, N. Jensen, A. Borch, C. Nøjgaard, S. Novovic, S. S. Kardasheva, A. Okhlobystin, T. Hauge, A. Waage, and J. B. Frøkjær, “Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: A study of 959 cases from the Scandinavian Baltic Pancreatic Club (SBPC) imaging database,” Pancreatology, 2021. doi:https://doi.org/10.1016/j.pan.2021.02.023[BibTeX] [Download PDF]
  • K. E. Fasmer, E. Hodneland, J. A. Dybvik, K. Wagner-Larsen, J. Trovik, Ø. Salvesen, C. Krakstad, and I. H. Haldorsen, “Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer,” Journal of Magnetic Resonance Imaging, vol. 53, iss. 3, pp. 928-937, 2021. doi:10.1002/jmri.27444[BibTeX] [Download PDF]
  • E. Hodneland, J. A. Dybvik, K. S. Wagner-Larsen, V. Solteszova, A. Z. Munthe-Kaas, K. E. Fasmer, C. Krakstad, A. Lundervold, A. S. Lundervold, Ø. Salvesen, B. J. Erickson, and I. Haldorsen, “Automated segmentation of endometrial cancer on MR images using deep learning,” Scientific Reports, vol. 11, iss. 1, p. 179, 2021. doi:10.1038/s41598-020-80068-9[BibTeX] [Download PDF]
  • H. Donkers, K. E. Fasmer, J. Mcgrane, J. M. A. Pijnenborg, R. Bekkers, I. S. Haldorsen, and K. Galaal, “The role of sarcopenic obesity in high-grade endometrial cancer,” International Journal of Gynecology & Obstetrics, 2021. doi:10.1002/ijgo.13591[BibTeX] [Download PDF]
  • H. Jacob, J. A. Dybvik, S. Ytre-Hauge, K. E. Fasmer, E. A. Hoivik, J. Trovik, C. Krakstad, and I. S. Haldorsen, “An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome and Specific Genetic Alterations in Endometrial Cancer,” Journal of Clinical Medicine, vol. 10, iss. 3, 2021. doi:10.3390/jcm10030538[BibTeX] [Download PDF]
  • H. Donkers, K. E. Fasmer, J. Mcgrane, J. M. A. Pijnenborg, R. Bekkers, I. S. Haldorsen, and K. Galaal, “Obesity and visceral fat: Survival impact in high-grade endometrial cancer,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 256, pp. 425-432, 2021. doi:10.1016/j.ejogrb.2020.11.050[BibTeX] [Download PDF]
  • D. Forsse, H. F. Berg, O. Bozickovic, H. Engerud, M. K. Halle, E. A. Hoivik, K. Woie, H. M. J. Werner, I. S. Haldorsen, J. Trovik, and C. Krakstad, “Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer,” Gynecologic Oncology, 2020. doi:10.1016/j.ygyno.2020.12.002[BibTeX] [Download PDF]
  • E. Mörth, K. Wagner-Larsen, E. Hodneland, C. Krakstad, I. Haldorsen, S. Bruckner, and N. Smit, “RadEx: Integrated Visual Exploration of Multiparametric Studies for Radiomic Tumor Profiling,” , vol. 39, iss. 7, pp. 611-622, 2020. doi:10.1111/cgf.14172[BibTeX] [Download PDF]
  • E. Mörth, I. S. Haldorsen, S. Bruckner, and N. N. Smit, “ParaGlyder: Probe-driven Interactive Visual Analysis for Multiparametric Medical Imaging Data,” in Advances in Computer Graphics, 2020, pp. 351-363. doi:10.1007/978-3-030-61864-3_29[BibTeX] [Abstract] [Download PDF]
  • N. Moshina, H. S. Aase, A. S. Danielsen, I. S. Haldorsen, C. I. Lee, S. Zackrisson, and S. Hofvind, “Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial,” Radiology, 2020. doi:10.1148/radiol.2020201150[BibTeX] [Download PDF]
  • S. Ytre-Hauge, Ø. O. Salvesen, C. Krakstad, J. Trovik, and I. Haldorsen, “Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer,” Clinical Radiology, 2020. doi:10.1016/j.crad.2020.07.037[BibTeX] [Download PDF]
  • M. V. Lisitskaya, S. S. Olesen, P. Svarc, M. Ebrahim, A. B. Jensen, C. Nøjgaard, P. Nørregaard, A. M. Drewes, I. S. Haldorsen, T. Engjom, and others, “Systematic approach for assessment of imaging features in chronic pancreatitis: a feasibility and validation study from the Scandinavian Baltic Pancreatic Club (SBPC) database,” Abdominal Radiology, pp. 1-13, 2020. doi:10.1007/s00261-020-02466-x[BibTeX] [Download PDF]
  • A. Losnegård, L. A. Reisæter, O. J. Halvorsen, J. Jurek, J. Assmus, J. B. Arnes, A. Honoré, J. A. Monssen, E. Andersen, I. S. Haldorsen, and others, “Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate-and high-risk prostate cancer patients,” Acta Radiologica, p. 0284185120905066, 2020. doi:10.1177/0284185120905066[BibTeX] [Download PDF]
  • T. Engjom, E. Tjora, F. Erchinger, A. Madzak, G. Dimcevski, J. B. Frøkjær, and I. S. Haldorsen, “Secretin-Stimulated Magnetic Resonance Imaging Reveals Variable Diagnostic Accuracy According to Etiology in Pancreatic Disease,” Pancreas, vol. 49, iss. 3, pp. 361-367, 2020. doi:10.1097/MPA.0000000000001491[BibTeX] [Download PDF]
  • C. Reijnen, E. Gogou, N. C. M. Visser, H. Engerud, J. Ramjith, L. J. M. van der Putten, K. van de Vijver, M. Santacana, P. Bronsert, J. Bulten, M. Hirschfeld, E. Colas, A. Gil-Moreno, A. Reques, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, and others, “Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study,” PLOS Medicine, vol. 17, iss. 5, pp. 1-19, 2020. doi:10.1371/journal.pmed.1003111[BibTeX] [Abstract] [Download PDF]
  • H. F. Berg, Z. Ju, M. Myrvold, K. E. Fasmer, M. K. Halle, E. A. Hoivik, S. N. Westin, J. Trovik, I. S. Haldorsen, G. B. Mills, and others, “Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma,” British Journal of Cancer, pp. 1-9, 2020. doi:10.1038/s41416-020-0745-6[BibTeX] [Download PDF]
  • K. E. Fasmer, A. Gulati, J. A. Dybvik, S. Ytre-Hauge, Ø. Salvesen, J. Trovik, C. Krakstad, and I. S. Haldorsen, “Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer,” European Radiology, pp. 1-11, 2020. doi:10.1007/s00330-019-06622-w[BibTeX] [Download PDF]
  • T. Fonnes, E. Strand, K. E. Fasmer, H. F. Berg, H. Espedal, K. Sortland, I. Stefansson, L. Bjørge, I. S. Haldorsen, C. Krakstad, and others, “Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models,” Cancers, vol. 12, iss. 2, p. 370, 2020. doi:10.3390/cancers12020370[BibTeX] [Download PDF]
  • H. Engerud, H. F. Berg, M. Myrvold, M. K. Halle, L. Bjorge, I. S. Haldorsen, E. A. Hoivik, J. Trovik, and C. Krakstad, “High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer,” Gynecologic Oncology, 2020. doi:10.1016/j.ygyno.2020.01.020[BibTeX] [Download PDF]
  • E. Strand, I. L. Tangen, K. E. Fasmer, H. Jacob, M. K. Halle, E. A. Hoivik, B. Delvoux, J. Trovik, I. S. Haldorsen, A. Romano, and others, “Blood Metabolites Associate with Prognosis in Endometrial Cancer,” Metabolites, vol. 9, iss. 12, p. 302, 2019. doi:10.3390/metabo9120302[BibTeX] [Download PDF]
  • D. Forsse, I. Tangen, K. Fasmer, M. Halle, K. Viste, B. Almås, B-E. Bertelsen, J. Trovik, I. Haldorsen, and C. Krakstad, “Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling,” Gynecologic Oncology, 2019. doi:10.1016/j.ygyno.2019.11.123[BibTeX] [Download PDF]
  • H. Espedal, T. Fonnes, K. E. Fasmer, C. Krakstad, and I. S. Haldorsen, “Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy,” Cancers, vol. 11, iss. 12, p. 1885, 2019. doi:10.3390/cancers11121885[BibTeX] [Download PDF]
  • C. Reijnen, J. IntHout, L. F. Massuger, F. Strobbe, H. V. Küsters-Vandevelde, I. S. Haldorsen, M. P. Snijders, and J. M. Pijnenborg, “Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis,” The Oncologist 2019, 2019. doi:10.1634/theoncologist.2019-0117[BibTeX] [Download PDF]
  • I. S. Haldorsen, N. Lura, J. Blaakær, D. Fischerova, and H. M. J. Werner, “What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?,” Current Oncology Reports, vol. 21, iss. 9, p. 77, 2019. doi:10.1007/s11912-019-0824-0[BibTeX] [Download PDF]
  • W. J. van Weelden, K. E. Fasmer, I. L. Tangen, J. IntHout, K. Abbink, A. E. van Herwaarden, C. Krakstad, L. F. Massuger, I. S. Haldorsen, and J. M. Pijnenborg, “Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study,” BMC Cancer, vol. 19, iss. 1, p. 547, 2019. doi:10.1186/s12885-019-5770-6[BibTeX] [Download PDF]
  • C. Reijnen, W. J. van Weelden, M. S. Arts, J. P. Peters, P. F. Rijken, K. Van de Vijver, M. Santacana, P. Bronsert, J. Bulten, M. Hirschfeld, E. Colas, A. Gil-Moreno, A. Reques, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, J. Huvila, M. Koskas, V. Weinberger, L. Minar, E. Jandakova, M. P. L. M. Snijders, S. van den Berg-van Erp, H. V. N. Kusters-Vandevelde, X. Matias-Guiu, F. Amant, ENITEC-consortium, L. F. A. G. Massuger, J. Bussink, and J. M. A. Pijnenborg, “Poor outcome in hypoxic endometrial carcinoma is related to vascular density,” British journal of cancer, vol. 120, iss. 11, p. 1037, 2019. doi:10.1038/s41416-019-0461-2[BibTeX] [Download PDF]
  • S. Hofvind, Å. S. Holen, H. S. Aase, N. Houssami, S. Sebuødegård, T. A. Moger, I. S. Haldorsen, and L. A. Akslen, “Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial,” The Lancet Oncology, vol. 20, iss. 6, pp. 795-805, 2019. doi:10.1016/S1470-2045(19)30161-5[BibTeX] [Download PDF]
  • H. S. Aase, Å. S. Holen, K. Pedersen, N. Houssami, I. S. Haldorsen, S. Sebuødegård, B. Hanestad, and S. Hofvind, “A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial,” European radiology, vol. 29, iss. 3, pp. 1175-1186, 2019. doi:10.1007/s00330-018-5690-x[BibTeX] [Download PDF]
  • H. Engerud, K. Hope, H. F. Berg, K. E. Fasmer, I. L. Tangen, I. S. Haldorsen, J. Trovik, and C. Krakstad, “Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer,” PloS one, vol. 14, iss. 1, p. e0210585, 2019. doi:10.1371/journal.pone.0210585[BibTeX] [Download PDF]
  • I. L. Tangen, K. E. Fasmer, G. F. Konings, A. Jochems, B. Delvoux, S. Xanthoulea, T. Stokowy, E. Strand, H. F. Berg, S. Auriola, J. Trovik, M. R. Häkkinen, and I. S. Haldorsen, “Blood steroids are associated with prognosis and fat distribution in endometrial cancer,” Gynecologic oncology, 2018. doi:10.1016/j.ygyno.2018.10.024[BibTeX] [Download PDF]
  • V. R. Bollineni, S. Ytre-Hauge, A. Gulati, M. K. Halle, K. Woie, Ø. Salvesen, J. Trovik, C. Krakstad, and I. S. Haldorsen, “The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients,” European Journal of Hybrid Imaging, vol. 2, iss. 1, p. 24, 2018. doi:10.1186/s41824-018-0042-2[BibTeX] [Download PDF]
  • S. Ytre-Hauge, J. A. Dybvik, A. Lundervold, Ø. O. Salvesen, C. Krakstad, K. E. Fasmer, H. M. Werner, B. Ganeshan, E. Hoivik, L. Bjørge, J. Trovik, and I. Haldorsen, “Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer,” Journal of Magnetic Resonance Imaging, vol. 48, iss. 6, pp. 1637-1647, 2018. doi:10.1002/jmri.26184[BibTeX] [Download PDF]
  • J. B. Frøkjær, F. Akisik, A. Farooq, B. Akpinar, A. Dasyam, A. M. Drewes, I. S. Haldorsen, G. Morana, J. P. Neoptolemos, S. S. Olesen, M. Petrone, A. Sheel, T. Shimosoegawa, and D. Whitcomb, “Guidelines for the Diagnostic Cross Sectional Imaging and Severity Scoring of Chronic Pancreatitis,” Pancreatology, vol. 18, iss. 7, pp. 764-773, 2018. doi:10.1016/j.pan.2018.08.012[BibTeX] [Download PDF]
  • G. Konings, N. Saarinen, B. Delvoux, L. Kooreman, P. Koskimies, C. Krakstad, K. Fasmer, I. Haldorsen, A. Zaffagnini, M. Häkkinen, S. Auriola, L. Dubois, N. Lieuwes, F. Verhaegen, L. Schyns, R. Kruitwagen, E. Consortium, S. Xanthoulea, and R. A, “Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure,” International journal of molecular sciences, vol. 19, iss. 9, p. 2547, 2018. doi:10.3390/ijms19092547[BibTeX] [Download PDF]
  • T. Engjom, G. Kavaliauskiene, E. Tjora, F. Erchinger, G. Wathle, B. N. Lærum, R. Pål. Njølstad, F. J. Brøndum, O. H. Gilja, G. Dimcevski, and I. S. Haldorsen, “Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI,” PloS one, vol. 13, iss. 7, p. e0201019, 2018. doi:10.1371/journal.pone.0201019[BibTeX] [Download PDF]
  • T. Fonnes, J. Trovik, P. Edqvist, K. E. Fasmer, J. Marcickiewicz, S. Tingulstad, A. C. Staff, L. Bjørge, F. Amant, I. S. Haldorsen, H. Werner, L. Akslen, I. Tangen, and C. Krakstad, “Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 125, iss. 13, pp. 1695-1703, 2018. doi:10.1111/1471-0528.15403[BibTeX] [Download PDF]
  • K. Fuglsang, I. S. Haldorsen, E. A. Lundqvist, G. Lindahl, H. Roed, K. Woie, P. Pakarinen, A. Thoroddsen, M. Anttila, and J. Blaakær, “Cervical cancer staging, pretreatment planning and surgical treatment in the Nordic countries–survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology,” Acta Obstetricia et Gynecologica Scandinavica, 2018. doi:10.1111/aogs.13388[BibTeX] [Download PDF]
  • T. Engjom, K. D. Pham, F. Erchinger, I. S. Haldorsen, O. H. Gilja, G. Dimcevski, and R. F. Havre, “Good Agreement Between Transabdominal and Endoscopic Ultrasound of the Pancreas in Chronic Pancreatitis,” Ultraschall in der Medizin-European Journal of Ultrasound, 2018. doi:10.1055/a-0583-8254[BibTeX] [Download PDF]
  • K. E. Fasmer, A. Bjørnerud, S. Ytre-Hauge, R. Grüner, I. L. Tangen, H. M. Werner, L. Bjørge, Ø. O. Salvesen, J. Trovik, C. Krakstad, and I. Haldorsen, “Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer,” Acta Radiologica, vol. 59, iss. 8, pp. 1010-1017, 2018. doi:10.1177/0284185117740932[BibTeX] [Download PDF]
  • T. Engjom, E. Tjora, G. Wathle, F. Erchinger, B. N. Lærum, O. H. Gilja, I. S. Haldorsen, and G. Dimcevski, “Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging,” European radiology, vol. 28, iss. 4, pp. 1495-1503, 2018. doi:10.1007/s00330-017-5115-2[BibTeX] [Download PDF]
  • S. Ytre-Hauge, M. Esmaeili, T. E. Sjøbakk, R. Grüner, K. Woie, H. M. Werner, C. Krakstad, L. Bjørge, Ø. O. Salvesen, I. M. Stefansson, J. Trovik, B. TF, and I. Haldorsen, “In vivo MR spectroscopy predicts high tumor grade in endometrial cancer,” Acta Radiologica, vol. 59, iss. 4, pp. 497-505, 2018. doi:10.1177/0284185117733297[BibTeX] [Download PDF]
  • S. Hofvind, N. Moshina, Å. Holen, A. S. Danielsen, C. I. Lee, N. Houssami, H. S. Aase, L. A. Akslen, and I. S. Haldorsen, “Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening,” Radiology, p. 203936. doi:10.1148/radiol.2021203936[BibTeX] [Download PDF]

 

 

Twitter